Roche committed to innovation and growth
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
List view / Grid view
News
Pfizer receives EU Marketing Authorization for INLYTA®(Axitinib)
4 September 2012 | By Pfizer
The European Commission has granted marketing authorization for INLYTA® (axitinib)...
Lilly Diabetes launches mobile application for those who support people with Type 1 diabetes
4 September 2012 | By Eli Lilly and Company
Lilly Diabetes launches Lilly Glucagon Mobile App to support #diabetes caregivers...
Tecan and Siloam Biosciences co-market new ELISA system
Tecan and Siloam Biosciences Inc. announce their intent to co-market a new automated low volume, high sensitivity microfluidic ELISA...
U.S. Food and Drug Administration approves BOSULIF® (bosutinib)
4 September 2012 | By Pfizer
“BOSULIF is the third new medicine to be approved by the FDA in just 13 months..."
Republic of Uganda and Merck launch cervical cancer vaccination program
4 September 2012 | By Merck
Cervical cancer is the most common cancer among women in Uganda...
Revestive® (teduglutide) receives European marketing authorization for the treatment of adults with Short Bowel Syndrome (SBS)
4 September 2012 | By F T I Consulting
The European Commission has granted European market authorization for the medicinal product teduglutide...
SPIRIVA®* celebrates 10 years of ongoing commitment to patients and advancing clinical innovation in COPD
3 September 2012 | By Boehringer Ingelheim
SPIRIVA® is the most prescribed COPD maintenance treatment worldwide...
Novartis data at ERS shows efficacy of once-daily COPD portfolio versus comparators, further establishes dual-bronchodilator QVA149
3 September 2012 | By Novartis
Further data from the COPD clinical trial programs...
Phase III results: tiotropium* Respimat® significantly reduces exacerbations in asthma patients still symptomatic despite ICS/LABA treatment
3 September 2012 | By Boehringer Ingelheim
“These results exceeded our expectations..."
NextPharma appoints three new senior team members
30 August 2012 | By Virgo HEALTH
NextPharma Technologies Holding Limited, is delighted to announce the appointment of two key additions to its executive team...
Novartis QVA149 Phase III study meets primary endpoint in reducing exacerbations in COPD patients, filing in EU and Japan by end of year
30 August 2012 | By Novartis
SPARK met its primary endpoint...
New bottle for Ingelvac MycoFLEX® simplifies mixing with Ingelvac CircoFLEX®
30 August 2012 | By Boehringer Ingelheim
European approval for the MycoFLEX® Headspace bottle...
Abbott’s HUMIRA® (Adalimumab) approved in Europe for expanded treatment of Crohn’s Disease (CD)
30 August 2012 | By Abbott
Approval extends HUMIRA indication to include moderately active Crohn's Disease...
Novartis International BioCamp highlights global R&D reach to meet patient needs in emerging markets
29 August 2012 | By Novartis
Novartis welcomed its annual International Biotechnology Leadership Camp...
